Healthcare provider profile · identity verified

Marshe Ivy, NP

Nurse Practitioner · ELK GROVE, CA · NPI 1386308955

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	2274	122
Amlodipine Besylate	Amlodipine Besylate	1397	75
Gabapentin	Gabapentin	1177	65
Lisinopril	Lisinopril	1022	55
Furosemide	Furosemide	846	50
Pantoprazole Sodium	Pantoprazole Sodium	793	49
Metformin Hcl	Metformin Hcl	750	33
Trazodone Hcl	Trazodone Hcl	692	39
Losartan Potassium	Losartan Potassium	685	47
Tamsulosin Hcl	Tamsulosin Hcl	677	33
Clopidogrel	Clopidogrel Bisulfate	578	24
Levothyroxine Sodium	Levothyroxine Sodium	578	31
Carvedilol	Carvedilol	575	34
Quetiapine Fumarate	Quetiapine Fumarate	560	18
Metoprolol Tartrate	Metoprolol Tartrate	492	24
Famotidine	Famotidine	489	27
Metoprolol Succinate	Metoprolol Succinate	475	37
Eliquis	Apixaban	434	27
Memantine Hcl	Memantine Hcl	362	22
Escitalopram Oxalate	Escitalopram Oxalate	345	18
Divalproex Sodium	Divalproex Sodium	304	15
Glipizide	Glipizide	273	11
Omeprazole	Omeprazole	266	17
Donepezil Hcl	Donepezil Hcl	254	17
Duloxetine Hcl	Duloxetine Hcl	252	17
Levetiracetam	Levetiracetam	240	11
Risperidone	Risperidone	239	suppressed
Sertraline Hcl	Sertraline Hcl	211	13
Buspirone Hcl	Buspirone Hcl	195	12
Hydralazine Hcl	Hydralazine Hcl	195	16
Citalopram Hbr	Citalopram Hydrobromide	191	suppressed
Montelukast Sodium	Montelukast Sodium	184	14
Hydrochlorothiazide	Hydrochlorothiazide	182	20
Potassium Chloride	Potassium Chloride	176	14
Baclofen	Baclofen	175	12
Spironolactone	Spironolactone	169	12
Alendronate Sodium	Alendronate Sodium	168	13
Tradjenta	Linagliptin	166	suppressed
Mirtazapine	Mirtazapine	164	12
Jardiance	Empagliflozin	163	17
Fluoxetine Hcl	Fluoxetine Hcl	160	suppressed
Ibuprofen	Ibuprofen	138	33
Simvastatin	Simvastatin	138	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	136	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	133	36
Allopurinol	Allopurinol	131	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	130	suppressed
Januvia	Sitagliptin Phosphate	130	suppressed
Propranolol Hcl	Propranolol Hcl	130	suppressed
Bupropion Xl	Bupropion Hcl	127	suppressed
Entresto	Sacubitril/Valsartan	125	suppressed
Glipizide Er	Glipizide	122	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	122	15
Paroxetine Hcl	Paroxetine Hcl	117	suppressed
Lovastatin	Lovastatin	115	suppressed
Benazepril Hcl	Benazepril Hcl	113	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	113	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	108	suppressed
Clonidine Hcl	Clonidine Hcl	100	suppressed
Myrbetriq	Mirabegron	100	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	98	suppressed
Fluticasone Propionate	Fluticasone Propionate	97	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	97	32
Ropinirole Hcl	Ropinirole Hcl	93	suppressed
Xarelto	Rivaroxaban	93	suppressed
Latanoprost	Latanoprost	88	16
Pravastatin Sodium	Pravastatin Sodium	79	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	78	suppressed
Olanzapine	Olanzapine	77	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	76	suppressed
Nifedipine Er	Nifedipine	73	suppressed
Meloxicam	Meloxicam	72	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	14
Finasteride	Finasteride	66	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	66	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	64	14
Tramadol Hcl	Tramadol Hcl	63	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	suppressed
Sucralfate	Sucralfate	61	suppressed
Topiramate	Topiramate	61	suppressed
Farxiga	Dapagliflozin Propanediol	58	suppressed
Metformin Hcl Er	Metformin Hcl	58	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	55	12
Carbamazepine	Carbamazepine	55	suppressed
Bupropion Hcl Sr	Bupropion Hcl	54	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	54	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	52	suppressed
Gemfibrozil	Gemfibrozil	52	suppressed
Alvesco	Ciclesonide	51	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	suppressed
Naltrexone Hcl	Naltrexone Hcl	51	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	50	suppressed
Lactulose	Lactulose	49	18
Ozempic	Semaglutide	49	suppressed
Digoxin	Digoxin	47	suppressed
Loxapine	Loxapine Succinate	47	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	46	11
Fenofibrate	Fenofibrate Nanocrystallized	45	suppressed
Glyburide	Glyburide	45	suppressed
Ezetimibe	Ezetimibe	44	suppressed
Trulicity	Dulaglutide	43	suppressed
Atenolol	Atenolol	42	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	40	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	39	12
Creon	Lipase/Protease/Amylase	39	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	39	suppressed
Ramipril	Ramipril	39	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	39	suppressed
Colchicine	Colchicine	38	suppressed
Nitroglycerin	Nitroglycerin	36	15
Triamcinolone Acetonide	Triamcinolone Acetonide	35	17
Brilinta	Ticagrelor	33	suppressed
Chlorthalidone	Chlorthalidone	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Pulmicort Flexhaler	Budesonide	31	suppressed
Bethanechol Chloride	Bethanechol Chloride	30	suppressed
Calcitriol	Calcitriol	30	suppressed
Incruse Ellipta	Umeclidinium Bromide	30	suppressed
Lorazepam	Lorazepam	30	suppressed
Megestrol Acetate	Megestrol Acetate	29	suppressed
Ultracare Pen Needle	Pen Needle, Diabetic	29	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	28	suppressed
Timolol Maleate	Timolol Maleate	27	suppressed
Lansoprazole	Lansoprazole	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	25	suppressed
Methocarbamol	Methocarbamol	25	suppressed
Ranolazine Er	Ranolazine	25	suppressed
Single Use Swab	Alcohol Antiseptic Pads	25	suppressed
Dapagliflozin	Dapagliflozin Propanediol	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	23	suppressed
Atrovent Hfa	Ipratropium Bromide	22	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	20	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	20	suppressed
Methotrexate	Methotrexate Sodium	20	suppressed
Naproxen	Naproxen	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	19	suppressed
Dulera	Mometasone/Formoterol	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Diltiazem Hcl	Diltiazem Hcl	17	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Nystop	Nystatin	16	suppressed
Icosapent Ethyl	Icosapent Ethyl	15	suppressed
Lacosamide	Lacosamide	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Azithromycin	Azithromycin	14	12
Ketoconazole	Ketoconazole	14	suppressed
Lagevrio (Eua)	Molnupiravir	14	14
Loperamide	Loperamide Hcl	14	suppressed
Glimepiride	Glimepiride	13	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	13	suppressed
Letrozole	Letrozole	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Ramelteon	Ramelteon	12	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Mesalamine	Mesalamine	11	suppressed
Prasugrel Hcl	Prasugrel Hcl	11	suppressed
Riluzole	Riluzole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error